The Latest Cardiac and Vascular News
LimFlow Nominates Pierre Guyot as Chairman of Board of Directors and Expands Senior Management Team PARIS–(BUSINESS WIRE)– LimFlow SA, a Paris-based medical device company dedicated to transforming treatment options for Critical Limb Ischemia (CLI), announced today changes to their board of directors by naming Pierre Guyot as the new chairman of […]
BOTHELL, Wash.–(BUSINESS WIRE)– BTG plc (LSE: BTG), the global healthcare company, today highlighted OPTALYSE PE one year trial results, presented at the International Society on Endovascular Therapy in Florida. The findings confirm that bilateral pulmonary embolism patients treated in as little as 2 hours with a total tissue plasminogen activator (tPA) dose […]
SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) — REVA Medical (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announces the appointment of Stephen Oesterle, MD to its Board of Directors, effective immediately. Dr. Oesterle brings significant clinical, medical device and board expertise to REVA. He is […]
IRVINE, Calif.–(BUSINESS WIRE)– Endologix Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today the completion of enrollment in the Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft (ELEVATE) IDE clinical study. The objective of the 75-patient study is to evaluate the safety and effectiveness of […]
Expro Elite™ Snare features a helical loop and Sympro Elite™ Snare features a simple 90-degree loop – both devices are available in five loop diameters for clinical versatility in retrieving or repositioning intravascular devices – preassembled, one-piece design allows rapid deployment through any 0.035” compatible lumen. WAYNE, Pa.–(BUSINESS WIRE)– Teleflex Incorporated (NYSE: […]
Feb. 2, 2018 14:00 UTC IRVINE, Calif.–(BUSINESS WIRE)– JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Laura A. Brenton as Vice President of Clinical and International Market […]
Feb. 1, 2018 19:16 UTC –ClearFlow spokespeople cite review article as latest piece of mounting evidence pertaining to urgent need for managing retained blood after surgery– ANAHEIM, Calif.–(BUSINESS WIRE)– ClearFlow, a medical device company based in Anaheim, CA., has announced that the cover of the January 2018 issue of The Annals of […]
Results from 236 patients across 28 sites in seven countries presented at LINC 2018 support growing body of evidence for pioneering clinical approach [01-February-2018] LEIPZIG, Germany, Feb. 1, 2018 /PRNewswire/ — An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for hemodialysis access was […]
First Patient Treated by Dr. Shigeru Saito at Shonan Kamakura General Hospital ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that it has commercially treated the first patient in […]
Procyrion Raises $16 Million Series C for Clinical Trials of Its Breakthrough Aortix Heart Pump Houston, TX (January 30, 2018) – Procyrion, Inc., a clinical-stage medical device company, today announced the completion of a $16 million Series C funding round led by an affiliate of Fannin Partners. Returning investors include […]
